Investing Chemicals in Oleander Leaf Extract as an Anti-breast Cancer | ||||
Journal of Bioscience and Applied Research | ||||
Article 29, Volume 11, Issue 2, June 2025, Page 725-730 PDF (1.02 MB) | ||||
Document Type: Original Article | ||||
DOI: 10.21608/jbaar.2025.370540.1172 | ||||
![]() | ||||
Authors | ||||
Haqi I. Ahmed1; Saif T. Abdulradh2; Duaa F. Hassan3 | ||||
1Chemistry, Ministry of Education, Baghdad Education Directorate / First Al-Rusafa, Iraq | ||||
2Chemistry, Ministry of Education, Babylon Education Directorate, Iraq | ||||
3pharmacology and toxicology, Ministry of Agriculture, Babylon Agriculture Directorate, Babylon, Iraq. | ||||
Abstract | ||||
Cancer is still crucial for the whole world and is a total burden on health; it is the main thing that we should investigate and find new therapeutic ways of treatment. This study investigates Oleander's (Nerium oleander) leaf extract's possible anticancer effects on human breast cancer cells in a test tube. Our study evaluated the cytotoxic effects of Oleander leaf extract on the Michigan Cancer Foundation-7(MCF-7) using the MTT assay. The results were compared with their effects on normal human dermal fibroblasts (HdFn). Preliminary results show differential cytotoxicity, with the extract demonstrating greater toxicity to MCF-7 cells compared to HdFn cells. This suggests a degree of selectivity in its anticancer activity, a desirable characteristic in cancer therapeutics. The antioxidant potential of the extract was studied using the DPPH assay. An IC50 value less than 50 μg/mL indicates a strong antioxidant activity (The highest activity was documented at a concentration of 12.5 ), whereas an IC50 value above 100 indicates weak activity | ||||
Keywords | ||||
MCF-7; anticancer; Oleander; Breast cancer; Breast anticancer | ||||
Statistics Article View: 115 PDF Download: 49 |
||||